Overview
What is Ballad Research Institute?
The Ballad Research Institute, situated in San Diego, California, is a nonprofit organization dedicated to facilitating the early stages of innovative research projects aimed at addressing human diseases. Their primary focus is on providing essential laboratory facilities and infrastructure to investigators engaged in pilot studies, high-risk/high-impact projects, or proof of concept studies. Recently, their researchers have made significant strides in the field of diabetes, identifying a novel immune cell type that plays a crucial role in inhibiting inflammation. Individuals with rapidly progressing type 1 diabetes have fewer of these cells, which may contribute to the severity of the disease. The institute's future research aims to understand how to increase the production of these cells to potentially slow or even reverse the progression of diabetes.
Official website here: www.ballad.org
Is Ballad Research Institute legitimate?
Ballad Research Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Ballad Research Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $95,109
For more financial information, click here
Official website here: www.ballad.org
What is the mission statement of Ballad Research Institute?
The Ballad Research Institute's mission is centered around supporting the early stages of projects aimed at treating human diseases. This can involve pilot studies, high-risk/high-impact projects, or proof of concept studies. The institute offers essential laboratory facilities and infrastructure to investigators embarking on these early development projects. Recently, Ballad scientists have discovered a new immune cell type in human blood, which appears to be scarce in children with rapidly progressing type 1 diabetes but more prevalent in those with less severe cases. These cells have been found to have the capacity to inhibit inflammation, which is significant given that diabetes is an inflammatory disease. The future focus of their research is to understand how to increase the production of these cells, potentially slowing or even reversing the progression of type 1 diabetes.
Official website here: www.ballad.org
Who is the CEO of Ballad Research Institute?
Joanna Davies is the Chair of Ballad Research Institute.
Official website here: www.ballad.org
What is the revenue of Ballad Research Institute?
Ballad Research Institute's revenue in 2022 was $289,346.
Official website here: www.ballad.org
Who are the executives of Ballad Research Institute and what are their salaries?
Here are 3 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.ballad.org
Where can I find the form 990 for Ballad Research Institute?
Ballad Research Institute's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.ballad.org
Learn more at the official website: www.ballad.org
Mission Statement of Ballad Research Institute
Ballad Research Institute is committed to supporting the early development of projects aimed at treating human diseases. This nonprofit organization focuses on providing necessary laboratory facilities and infrastructure to investigators embarking on innovative, high-risk, and high-impact projects, or proof of concept studies. The primary goal of Ballad Research Institute is to facilitate the initiation of such projects, which could potentially lead to significant breakthroughs in disease treatment.
Recently, Ballad scientists have made a notable discovery in the field of type 1 diabetes. They identified a new immune cell type in human blood, which appears to play a crucial role in inhibiting inflammation. Interestingly, children diagnosed with rapidly progressing type 1 diabetes have significantly fewer of these cells compared to those with less severe diabetes. This discovery could provide a potential explanation for the association between low cell counts and more severe disease progression. The research team at Ballad Research Institute is now exploring ways to increase the production of these cells as a potential strategy for slowing the progression or even reversing type 1 diabetes.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Ballad Research Institute is making significant strides in the early development of novel treatments for human diseases, particularly through its groundbreaking work on type 1 diabetes. Researchers at Ballad have identified a new immune cell type present in human blood, revealing critical differences between children with rapidly progressing type 1 diabetes and those with milder forms of the disease. The discovery that children with severe diabetes have fewer of these cells, while those with less severe conditions maintain nearly normal levels, opens new avenues for understanding the mechanisms underlying the disease.
Additionally, Ballad scientists have uncovered that these newly identified immune cells possess the capability to inhibit inflammation, which is vital given that diabetes is an inflammatory condition. This finding could provide an explanation for the correlation between low cell levels and more severe disease progression. Moving forward, Ballad aims to explore methods to increase the presence of these protective cells, with the potential goal of slowing the progression or even reversing type 1 diabetes.
Through providing essential laboratory facilities and infrastructure, Ballad Research Institute supports researchers in exploring high-risk and innovative projects that could transform the landscape of medical treatments. The work being done at Ballad not only offers hope to those affected by diabetes but also fosters broader advancements in the scientific community's understanding of immune regulation and inflammatory diseases.
This information is meant to be a general summary of Ballad Research Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Gross Receipts: $289,346
Assets and Liabilities:
- Total Assets: $520,000
- Total Liabilities: $514,876
- Net Assets: $5,124
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2014
Phone
(858) 200-7156Principal Officer
Joanna Davies
Main Address
3525 JOHN HOPKINS CT 200, SAN DIEGO, CA, 92121
Website
www.ballad.orgNTEE Category
Code: U05 - Science research
If you are a representative of Ballad Research Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.